-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cerebral small vessel disease (SVD) is the most important vascular factor leading to dementia, accounting for one-fifth of all strokes worldwi.
Cerebral small vessel disease (SVD) is the most important vascular factor leading to dementia, accounting for one-fifth of all strokes worldwi.
Figure 1: Paper cover image
Figure 1: Paper cover imageThe development of these lesions is associated with adverse functional outcomes, including cognitive decline, gait dysfunction, and depressi.
The development of these lesions is associated with adverse functional outcomes, including cognitive decline, gait dysfunction, and depressi.
New evidence shows that some patients with SVD have a reduction in lesio.
Therefore, studies with longer follow-up and serial follow-up MRI scans are needed to fully investigate the temporal dynamics of SVD and its determinan.
In this way, Mengfei Cai (Cai Mengfei) and Mina Jacob of the Nijmegen University Medical Center in the Netherlands, and others, used the RUN DMC small vessel disease cohort (Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort) established by Pr.
The RUNDMC cohort, enrolled 503 sporadic SVD patients (50-85 years old) in 2006 with baseline assessment and follow-up in 2011, 2015, and 202 Vascular risk factors and magnetic resonance imaging markers of SVD were assess.
In this study, a total of 382 patients with SVD (mean [SD] 61 [4]; 219 men and 163 women) who underwent at least 2 consecutive brain MRI scans with a mean (SD) follow-up of 115 ( 32) yea.
They found that the time course of SVD is highly variab.
Figure 2 The results of the paper
Figure 2 The results of the paperAbout 4% of patients experienced WMH net regression within 14 years, while 38 of 361 patients (15%), 5 of 296 patients (2%), and 61 of 231 patients (26%) WMH regressions appeared during 2006-2011, 2011-2015, and 2015-2020, respective.
About 4% of patients experienced WMH net regression within 14 years, while 38 of 361 patients (15%), 5 of 296 patients (2%), and 61 of 231 patients (26%) WMH regressions appeared during 2006-2011, 2011-2015, and 2015-2020, respective.
Of these, 29 (76%), 5 (100%) and 57 (93%) showed overall progression at 14 years of follow-up, taking into account all participants, the net WMH between the first and last scans The overall change is the net average progress in WMH over a 14-year peri.
Figure 3: Abstract of the paper image
Figure 3: Abstract of the paper imageOlder age was a strong predictor of faster WMH progression and the onset of lacu.
Older age was a strong predictor of faster WMH progression and the onset of lacu.
Furthermore, both baseline SVD lesion burden and vascular risk factors independently and synergistically predicted WMH progression, whereas only baseline SVD burden predicted new-onset lacune at 14 years of follow-.
The significance of this study lies in its findings: SVD shows marked progression over time, but mild WMH rarely develops clinically severe WM.
WMH regression is notable during some MRI intervals, although it may be generally compensated for by progression at long-term follow-.
SVD shows marked progression over time, but mild WMH rarely progresses to clinically severe WMH
Original source:Cai M, Jacob MA, van Loenen MR, et .
Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-.
_Stroke.
Published online May 4, 2022:11161/STROKEA.
1203809 doi: [11161/STROKEA.
12038099](https://d.
org/11161/STROKEA.
12038099)
Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-.
_Stroke.
Published online May 4, 2022:11161/STROKEA.
1203809 doi: [11161/STROKEA.
12038099](https://d.
org/11161/STROKEA.
12038099) Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-.
_Stroke_Leave a message here